Across TCGA pan-cancer cohorts, STRAP mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated STRAP data layer compared with 23 for mass-spec protein and 5 for mutation status.
The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where higher STRAP mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated STRAP expression acts as an unfavorable survival marker, although some lineages such as LUAD and LSCC show a favorable association.
CCRCC, LUAD, and LSCC are the cancer types where STRAP mass-spec protein most reproducibly stratifies survival.